Pelthos Therapeutics Inc.
PTHS
$23.06
-$0.14-0.60%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 26.78% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 26.78% | -- | |||
| Cost of Revenue | -27.81% | 349.88% | |||
| Gross Profit | 51.61% | 1,088.73% | |||
| SG&A Expenses | -5.90% | 622.79% | |||
| Depreciation & Amortization | 29.16% | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.04% | 604.80% | |||
| Operating Income | 21.87% | -375.54% | |||
| Income Before Tax | -71.14% | -384.30% | |||
| Income Tax Expenses | -1,388.60% | -- | |||
| Earnings from Continuing Operations | -33.42% | -370.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -33.42% | -370.82% | |||
| EBIT | 21.87% | -375.54% | |||
| EBITDA | 28.12% | -- | |||
| EPS Basic | -29.48% | 1.50% | |||
| Normalized Basic EPS | -64.44% | -1.32% | |||
| EPS Diluted | -29.48% | 1.50% | |||
| Normalized Diluted EPS | -64.44% | -1.32% | |||
| Average Basic Shares Outstanding | 3.04% | 377.99% | |||
| Average Diluted Shares Outstanding | 3.04% | 377.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||